Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-03-14

Clinical Trial Update: START - Early Thrombocyte Administration to Patients With Ruptured Abdominal Aortic Aneurism [NA]

View source ↗

Summary

This document provides an update on the START trial evaluating early thrombocyte (platelet) administration in patients with ruptured abdominal aortic aneurysm. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet transfusion (platelet transfusion)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Ruptured Abdominal Aortic Aneurism | NA | Status: UNKNOWN